Harvard Apparatus Regenerative Technology Q3 2026 Results: Net Loss of $1.46M, Loss Narrows
For the nine months ended September 30, 2026, Harvard Apparatus Regenerative Technology reported a net loss of $4.8 million, a slight improvement from the $5.2 million loss in the prior year period. While product revenue increased to $785,000, the company continues to operate with a significant accumulated deficit of $111.3 million and highlights its dependence on future capital raises to continue as a going concern.
- Key figure
- Net loss $1.46M